GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Byfavo® | CNS-7056 | CNS7056
remimazolam is an approved drug (FDA (2020), EMA (2021))
Compound class:
Synthetic organic
Comment: Remimazolam is a benzodiazepine type compound, that was developed as an ultra-short-acting sedative/anesthetic [3-4]. This compound combines the actions of the opioid analgesic remifentanil with that of the currently used sedative midazolam (GABAA receptor modulator). Remimazolam is proposed as a safer alternative to the current standard of care.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. EU EMA (2021) | US FDA (2020) |
IUPAC Name ![]() |
| methyl 3-[(4S)-8-bromo-2-methyl-6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9232 | remimazolam |
Synonyms ![]() |
| Byfavo® | CNS-7056 | CNS7056 |
Database Links ![]() |
|
| CAS Registry No. | 308242-62-8 |
| GtoPdb PubChem SID | 252166652 |
| PubChem CID | 9824461 |
| Search Google for chemical match using the InChIKey | GHUYIIGPWBMOGY-KRWDZBQOSA-N |
| Search Google for chemicals with the same backbone | GHUYIIGPWBMOGY |
| Search PubMed clinical trials | remimazolam |
| Search PubMed titles | remimazolam |
| Search PubMed titles/abstracts | remimazolam |
| UniChem Compound Search for chemical match using the InChIKey | GHUYIIGPWBMOGY-KRWDZBQOSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | GHUYIIGPWBMOGY-KRWDZBQOSA-N |